OptiNose(OPTN)03-20 00:55
$OptiNose(OPTN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001494650-24-000036 Size: 7 KB 网页链接查看全文
OptiNose(OPTN)03-20 00:45
$OptiNose(OPTN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001494650-24-000034 Size: 7 KB 网页链接查看全文
OptiNose(OPTN)03-20 00:55
$OptiNose(OPTN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001494650-24-000038 Size: 5 KB 网页链接查看全文
OptiNose(OPTN)03-15 04:35
$OptiNose(OPTN)$ 8-K Current report, items 1.01 and 8.01 Accession Number: 0001494650-24-000029 Act: 34 Size: 178 KB 网页链接查看全文
OptiNose(OPTN)03-16 03:45
$OptiNose(OPTN)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001494650-24-000031 Act: 34 Size: 225 KB 网页链接查看全文
OptiNose(OPTN)03-08 05:35
$OptiNose(OPTN)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001494650-24-000024 Act: 33 Size: 112 KB 网页链接查看全文
OptiNose(OPTN)03-07 20:05
$OptiNose(OPTN)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001494650-24-000017 Act: 34 Size: 2 MB 网页链接查看全文
OptiNose(OPTN)03-07 20:05
$OptiNose(OPTN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001494650-24-000018 Act: 34 Size: 9 MB 网页链接查看全文
OptiNose(OPTN)03-09 05:15
$OptiNose(OPTN)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001494650-24-000027 Act: 34 Size: 257 KB 网页链接查看全文
chuminhua2022-03-08 12:37
3月7日,Optinose$OptiNose(OPTN)$ 报告了 鼻喷剂III期ReOpen1 关键研究积极顶线结果,这表明慢性鼻窦炎患者在使用 XHANCE 后会有所改善,XHANCE 是一种“呼气”装置,可提供氟替卡松。
Optinose 表示,该试验共招募了 332 名患者,与安慰剂相比,该试验同时满足了两个共同主要终点。第一个是...查看全文
产业链观察2022-03-07 20:50
药闻▶2022 年 3 月 7 日— 专注于耳鼻喉 (ENT) 和过敏专家治疗的患者的制药公司$OptiNose(OPTN)$ ,今天宣布 ReOpen1 临床试验满足了其共同主要终点。
在接受 XHANCE®(丙酸氟替卡松)呼气输送系统™治疗的慢性鼻窦炎患者中显示出统计学上的显着改善在 ReOpen1 临...查看全文
破落鸭头2020-11-02 13:05
$OptiNose(OPTN)$ 这个公司的产品简单粗暴,有点搞笑。但鼻窦炎似乎是个很大的市场,拳头产品Xhance销量迅速增长,最近筹了4000万@5.85,专业投资人站在了山岗上
我觉得小散们可以上查看全文
$OptiNose(OPTN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001494650-21-000149 Size: 4 KB 网页链接
$OptiNose(OPTN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001494650-21-000151 Size: 5 KB 网页链接
$OptiNose(OPTN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001494650-21-000145 Size: 5 KB 网页链接
$OptiNose(OPTN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001494650-21-000147 Size: 5 KB 网页链接
$OptiNose(OPTN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001494650-21-000143 Size: 4 KB 网页链接
$OptiNose(OPTN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001494650-21-000141 Size: 4 KB 网页链接
$OptiNose(OPTN)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001494650-21-000139 Act: 34 Size: 266 KB 网页链接
$OptiNose(OPTN)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001567619-21-021254 Act: 33 Size: 13 KB 网页链接
$OptiNose(OPTN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001062993-21-011767 Size: 4 KB 网页链接
$OptiNose(OPTN)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001494650-21-000137 Act: 34 Size: 957 KB 网页链接